GB-6
Product Specifications
UNSPSC Description
GB-6 is a short linear peptide that targets the gastrin releasing peptide receptor (GRPR). GRPR is overexpressed in pancreatic cancer. Based on the tumor selectivity and tumor-specific accumulation properties of GB-6, GB-6 labeled with near infrared (NIR) fluorescent dyes or radionuclide netium-99m (99mTc) can be used as a high-contrast imaging probe. GB-6 has excellent in vivo stability, with tumor to pancreatic and intestinal fluorescence signal ratios of 5.2 and 6.3, respectively, in SW199 0 subcutaneous xenograft models. GB-6 can rapidly target tumors and accurately delineate tumor boundaries, which has broad application prospects[1].
Target Antigen
Bombesin Receptor; Radionuclide-Drug Conjugates (RDCs)
Type
Peptides
Related Pathways
Antibody-drug Conjugate/ADC Related;GPCR/G Protein
Applications
Cancer-programmed cell death
Field of Research
cancer
Assay Protocol
https://www.medchemexpress.com/gb-6.html
Solubility
10 mM in DMSO
Smiles
N[C@@H](CCC(N)=O)C(N[C@@H](CC1=CNC2=CC=C(O)C=C21)C(NCCC(N[C@@H](CCC)C(NCC(N[C@@H](CC3=CNC=N3)C(N)=O)=O)=O)=O)=O)=O
Molecular Weight
711.77
References & Citations
[1]Tu Y, et al. Novel GRPR-Targeting Peptide for Pancreatic Cancer Molecular Imaging in Orthotopic and Liver Metastasis Mouse Models. Anal Chem. 2023 Aug 1;95(30):11429-11439.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P5520/GB-6-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P5520/
Clinical Information
No Development Reported
CAS Number
2413262-74-3
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items